US 11021465
DNA-PK inhibitors
granted A61KA61K31/506A61K31/53
Quick answer
US patent 11021465 (DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/506, A61K31/53, A61K31/5377, A61K41/0038